glp-1 for ms You might know them as Ozempic, Wegovy, Mounjaro, and Zepbound. receptor agonists are best known managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective GLP-1s hold promise in MS,

Their primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels with a low risk of hypoglycaemia when used alone (though risk increases when combined with insulin or sulfonylureas) Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These combined effects result in improved glycaemic control for people with diabetes and significant weight loss

Focus on getting 20-30g protein per meal from plant sources

FAQs (Frequently Asked Questions) What is tirzepatide and how does it function as a weight loss medication

Endometriosis is not simply tissue growing outside the uterus

Vitamin D, a modulator of musculoskeletal health in chronic kidney disease